Abstract: Novel chiral derivitaves of non-nucleoside inhibitors (NNI), particularly R-isomers of halopyridyl and thiazoyl thiourea compounds are provided as potent inhibitors of reverse transcriptase (RT), and particularly of retroviral RT, most particularly HIV RT. The stereospecific compounds and compositions of the invention inhibit replication of retrovirus, particularly human immunodeficiency virus-1 (HIV-1) and drug resistant strains.
Type:
Application
Filed:
January 21, 2003
Publication date:
September 25, 2003
Applicant:
Parker Hughes Institute located at Roseville, Minnesota
Inventors:
Fatih M. Uckun, Taracad K. Venkatachalam